March 04, 2026
The simulators market size is forecast to increase from USD 14.71 billion in 2026 to USD 27.59 billion by 2035...
Read MoreJanuary 19, 2026
The U.S. digital health market size is forecast to increase from USD 98.69 billion in 2026 to USD 266.5 billio...
Read MoreDecember 24, 2025
The smart healthcare market is expected to rise from USD 397.98 billion in 2026 to USD 1833.7 billion by 2035,...
Read MoreJanuary 19, 2026
The anti-aging market size is forecast to grow from USD 84.41 billion in 2026 to USD 137.13 billion by 2035, g...
Read MoreMarch 18, 2026
Projections indicate that, biochip industry is projected to rise from USD 14.37 billion in 2025 to USD 47.5 billion by 2035, reflecting a CAGR of 12.7% over the next decade. The biochip market is growing because biochips have many applications, such as medical diagnostics, drug development, personalized medicine, continuous health monitoring, neuro...
March 18, 2026
Projections indicate that, point-of-care infectious disease testing industry is projected to rise from USD 12.42 billion in 2025 to USD 18.99 billion by 2035, reflecting a CAGR of 4.34% over the next decade. The point-of-care infectious disease testing market is expanding due to patient-centric care as well as increasing lateral flow test innovatio...
March 16, 2026
Based on our market forecasts, the U.S. AI-Driven diabetic retinopathy screening market was valued at USD 191.05 million in 2025 and is expected to grow from USD 231.59 million in 2026 to around USD 1308.85 million by 2035, expanding at a CAGR of 21.22% during 2026–2035....
March 16, 2026
According to market projections, the global allergy diagnostics market, valued at USD 6.42 billion in 2025, is anticipated to reach USD 18.18 billion by 2035, growing at a CAGR of 10.96% over the next decade. The rising incidence of allergies and technological advancements bolster market growth. North America dominated the global market due to the ...
March 12, 2026
According to market projections, the global lateral flow assays market, valued at USD 12.76 billion in 2025, is anticipated to reach USD 27.40 billion by 2035, growing at a CAGR of 7.94% over the next decade. The lateral flow assays market is expanding due to growing demand for point-of-care testing as well as growing development of multiplex and...
March 12, 2026
Projections indicate that, the global single cell analysis market will increase from USD 6.16 billion in 2025 to USD 34.33 billion by 2035, experiencing a CAGR of 18.74% over the next 10 years. Across the world, growing cancer incidents and chronic diseases are fueling the growth of the market. However, North America dominated the market in 2024, d...
March 11, 2026
Based on our market research, the neurodiagnostics market was valued at USD 19.05 billion in 2025 and is projected to grow from USD 20.68 billion in 2026 to USD 43.27 billion by 2035, expanding at a CAGR of 8.55% during 2026–2035...
March 11, 2026
Market insights predict, the North America in-vitro diagnostics industry is expected to grow from USD 54.09 billion in 2025 to USD 90.05 billion by 2035, driven by a CAGR of 5.23%. In 2024, reagents led North America's in-vitro diagnostics market. Services and homecare are set to grow fastest. Immunoassays dominated tech, while microbiology and onc...
March 10, 2026
Market insights predict, the in vitro diagnostics industry is expected to grow from USD 85.1 billion in 2025 to USD 131.52 billion by 2035, driven by a CAGR of 4.45%. With the growing number of people and various diseases, the need for in vitro diagnostics has grown, and it is expected that the demand for in vitro diagnostics will continue in the f...
March 06, 2026
Projections indicate that, cancer biomarkers industry is projected to rise from USD 38.62 billion in 2025 to USD 128 billion by 2035, reflecting a CAGR of 12.73% over the next decade. he advancement in technology and growing integration of AI in R&D and other aspects of oncology is increasing the growth of the market....
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com